Your browser doesn't support javascript.
loading
Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
Salazar, M R; Carbajal, H A; Espeche, W G; Aizpurúa, M; Dulbecco, C A; Reaven, G M.
Afiliação
  • Salazar MR; Hospital Universitario General San Martín, La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, UNLP, Argentina. Electronic address: salazarlandea@gmail.com.
  • Carbajal HA; Facultad de Ciencias Médicas, UNLP, Argentina.
  • Espeche WG; Hospital Universitario General San Martín, La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, UNLP, Argentina.
  • Aizpurúa M; Hospital Municipal de Rauch, Buenos Aires, Argentina.
  • Dulbecco CA; Hospital Universitario General San Martín, La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, UNLP, Argentina.
  • Reaven GM; Stanford University School of Medicine, Stanford, CA, USA.
Nutr Metab Cardiovasc Dis ; 27(4): 366-373, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28254109
ABSTRACT
BACKGROUND AND

AIMS:

Insulin resistance is associated with a cluster of abnormalities that increase cardiovascular disease (CVD). Several indices have been proposed to identify individuals who are insulin resistant, and thereby at increased CVD risk. The aim of this study was to compare the abilities of 3 indices to accomplish that goal 1) plasma triglyceride × glucose index (TG × G); 2) plasma triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C); and 3) Metabolic Syndrome (MetS). METHODS AND

RESULTS:

In a population sample of 723 individuals (486 women and 237 men, 50 ± 16 and 51 ± 16 years old, respectively), baseline demographic and metabolic variables known to increase CVD risk and incident CVD were compared among individuals defined as high vs. low risk by TG × G; TG/HDL-C; or MetS. CVD risk profiles appeared comparable in high risk subjects, irrespective of criteria. Crude incidence of CVD events was increased in high risk

subjects:

12.2 vs. 5.3% subjects/10 years, p = 0.005 defined by TG/HDL-C; 13.4 vs. 5.3% subjects/10 years, p = 0.002 defined by TG × G; and 13.4% vs. 4.5% of subjects/10 years, p < 0.001 in subjects with the MetS. The area under the ROC curves to predict CVD were similar, 0.66 vs. 0.67 for TG/HDL-C and TG × G, respectively. However, when adjusted by age, sex and multiple covariates, hazard ratios for incident CVD were significantly increased in high risk patients classified by either TG/HDL-C ratio (2.18, p = 0.021) or MetS (1.93, p = 0.037), but not by TG × G index (1.72, p = 0.087).

CONCLUSION:

Although the 3 indices identify CVD risk comparably, the TG × G index seems somewhat less effective at predicting CVD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triglicerídeos / Glicemia / Resistência à Insulina / Síndrome Metabólica / Diabetes Mellitus Tipo 2 / Hipertensão / HDL-Colesterol Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triglicerídeos / Glicemia / Resistência à Insulina / Síndrome Metabólica / Diabetes Mellitus Tipo 2 / Hipertensão / HDL-Colesterol Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article